Optimal management of primary and secondary mitral regurgitation;Sinnvolle diagnostik und therapieplanung bei organischer und relativer mitralklappeninsuffizienz

Herz

Volumn 23, Issue 7, 1998, Pages 429-433

  Piper, Cornelia ^a   Wiemer, Marcus ^a   Schultheiß, Heinz Peter ^a   Horstkotte, Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ACE inhibitors; Grading of severity; Indication for surgical intervention; Medical therapy; Mitral regurgitation; Stress tests

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; EXERCISE TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PROGNOSIS; REVIEW; SCINTIANGIOGRAPHY;

EID: 0031785366     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03043403     Document Type: Review

References (17)

1. Acar J, Michel PL, Luxereau P, et al. Indication for surgery in mitral regurgitation. Eur Heart J 1991;12:Suppl B:52-4.
2. Carabello BA, Crawford FA. Medical progress: valvular heart disease. N Engl J Med 1997;337:32-41.
3. Dujardin KS, Enriquenz-Serrano M, Seward J. A prospective trial on the effects of Losartan on the degree of mitral regurgitation. Circulation 1997;95:Suppl I:468.
4. Greenberg BH, de Mots H, Murphy E, et al. Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long term clinical follow up. Circulation 1982;65:181-7.
5. Hall SA, Brickner ME, Willett DL, et al. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation 1997;95:636-42.
6. Horstkotte D. Lebensqualität und Optimierung der Lebensqualität nach Herzklappeneratz. In: Blum U, von der Emde J, Hrsg. Diagnostik und operative Behandlung kardialer Erkrankungen. Darmstadt: Steinkopff, 1994:53-71.
7. Horstkotte D. Erworbene Herzklappenfehler. München-Wien-Baltimore: Urban & Schwarzenberg, 1987.
8. Leung DY, Griffin BP, Stewart WJ, et al. Left ventricular function after valve repair for chronic mitral regurgitation: predicitve value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996;28:1198-205.
9. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-91.
10. Oral H, Bradley S., Supiano M, et al. Cyokine expression in patients with chronic mitral regurgitation. Circulation 1997;Suppl I: 469, 2623.
11. Pieper EPG, Hellemans IM, Hamer HPM, et al. Value of systolic pulmonary venous flow reversal and color doppler jet measurements assessed with transesophageal echocardiography in recognizing severe pure mitral regurgitation. Am J Cardiol 1996; 78:444-50.
12. Ross J. The timing of surgery for severe mitral regurgitation. N Engl J Med 1996;335:1456-8.
13. Schön HR, Schröter G, Barthel P, et al. Qumalapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994; 3:303-12.
14. Starling MR, Petrusha JA, Bach DS, et al. Activation of the sympathetic nervous system in chronic mitral regurgitation. Circulation 1997;Suppl I:469,2619.
15. Thomas JD. How leaky is that mitral valve? Circulation 1997; 95:548-50.
16. Wisenbaugh T, Esop R, Rothlisberger C, et al. Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 1992;69:348-53.
17. Yamachika S, Reid CL, Savani D, et al. Usefulness of color Doppler proximal isovelocity surface area method on quantitating valvular regurgitation J Am Soc Echocardiogr 1997;10: 159-68.